Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa 1 min read Main News Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa AETOSWire October 14, 2023 London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive license...Read More
